Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-3021
Hofmann-Lehmann, R; Cattori, V; Tandon, R; Boretti, F S; Meli, M L; Riond, B; Pepin, A C; Willi, B; Ossent, P; Lutz, H (2007). Vaccination against the feline leukaemia virus: outcome and response categories and long-term follow-up. Vaccine, 25(30):5531-5539.
|PDF - Registered users only|
Feline leukaemia virus (FeLV) is a pathogen inducing fatal disease in cats worldwide. By applying sensitive molecular assays, efficacious commonly used FeLV vaccines that protect cats from antigenaemia were found not to prevent proviral integration and minimal viral replication after challenge. Nonetheless, vaccines protected cats from FeLV-associated disease and prolonged life expectancy. The spectrum of host response categories was refined by investigating plasma viral RNA loads. All cats initially fought similar virus loads, although subsequently loads were associated with infection outcomes. Persistence of plasma viral RNA was moderately associated with reactivation of FeLV infection. In conclusion, sensitive molecular assays are important tools for reviewing pathogenesis of FeLV infection.
|Item Type:||Journal Article, refereed, original work|
|Communities & Collections:||05 Vetsuisse Faculty > Veterinary Clinic > Department of Farm Animals > Clinical Laboratory|
05 Vetsuisse Faculty > Institute of Veterinary Pathology
|DDC:||570 Life sciences; biology|
|Deposited On:||18 Aug 2008 09:21|
|Last Modified:||27 Nov 2013 18:01|
|Citations:||Web of Science®. Times cited: 25|
Users (please log in): suggest update or correction for this item
Repository Staff Only: item control page